Precigen, Inc. Stock Analysis & AI Score
Precigen, Inc. (PGEN) has an ST Score of 58.4 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $18.00 price target (+163.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIPGEN Stock Price History
PGEN Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
PGEN Latest Stock News
ST Score
Precigen, Inc. (PGEN) has an ST Score of 58.4 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $18.00 price target (+163.5% upside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD+
All factor grades
- SentimentA+
- MomentumA
- ForecastA
- GrowthB+
- ValuationC
- ProfitabilityD+
- Financial StrengthD+
- Piotroski4/9
Press Releases
Company Contact Details
PGEN stock: frequently asked questions
What is PGEN's ST Score?
Precigen, Inc. (PGEN) has an ST Score of 58.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PGEN a buy, hold, or sell?
Analysts rate PGEN a Buy, with a price target of $18.00 (+163.5% vs the current price). Our ST Score grades it B- (58.4/100). The ST Score is a data-driven signal, not a recommendation.
What are PGEN's factor grades?
Valuation C, Profitability D+, Financial Strength D+, Momentum A, Growth B+, Forecast A, Sentiment A+.
What is PGEN's valuation grade?
Precigen, Inc. (PGEN) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PGEN's growth grade?
Precigen, Inc. (PGEN) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PGEN's profitability grade?
Precigen, Inc. (PGEN) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PGEN's financial strength grade?
Precigen, Inc. (PGEN) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PGEN?
The average analyst price target for Precigen, Inc. (PGEN) is $18.00 from 16 analysts, which is +163.5% versus the recent price of $6.83.
What is PGEN's Piotroski score?
Precigen, Inc. (PGEN) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.